Submitted for Publication: March 11, 2014; final revision received May 7, 2014; accepted June 6, 2014.
Published Online: October 29, 2014. doi:10.1001/jamapsychiatry.2014.1337.
Study concept and design: Scott, Kessler.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Scott.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Scott, Lim.
Obtained funding: Scott, Andrade, Borges, Caldas-de-Almeida, Gureje, Karam, Kawakami, Levinson, Navarro-Mateu, Posada-Villa, Torres, Williams.
Administrative, technical, or material support: Gureje, Hu, Karam, Lee, Posada-Villa, Torres.
Study supervision: Scott.
Conflict of Interest Disclosures: Dr Karam has received unrestricted support for his research from AstraZeneca, Eli Lilly and Company, GalaxoSmithKline, Hikma Pharmaceuticals, Janssen Cilag, Lundbeck, Novartis, and Servier. Dr Kessler has been a consultant for Analysis Group, GlaxoSmithKline Inc, Kaiser Permanente, Merck & Co, Inc, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Sanofi-Aventis Groupe, Shire US Inc, SRA International, Inc, Takeda Global Research & Development, Transcept Pharmaceuticals Inc, Wellness and Prevention, Inc, and Wyeth-Ayerst; has served on advisory boards for Eli Lilly and Company, Mindsite, and Wyeth-Ayerst; and has had research support for his epidemiologic studies from Analysis Group Inc, Bristol-Myers Squibb, Eli Lilly and Company, EPI-Q, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Sanofi-Aventis Groupe, and Shire US, Inc. He owns stock in Datastat, Inc. No other disclosures were reported.
Funding/Support: The World Health Organization (WHO) World Mental Health (WMH) Survey Initiative is supported by the US National Institute of Mental Health (NIMH) (grant R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (grants R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (grant FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. The São Paulo Megacity Mental Health Survey (Brazil) is supported by the State of São Paulo Research Foundation Thematic Project grant 03/00204-3. The Bulgarian Epidemiological Study of Common Mental Disorders (2014 EPIBUL) is supported by the Ministry of Health and the National Center for Public Health Protection. The Colombian National Study of Mental Health is supported by the Ministry of Social Protection. The Mental Health Study Medellín–Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellín. Implementation of the Iraq Mental Health Survey and data entry were carried out by the staff of the Iraqi Ministry of Health and Ministry of Planning with direct support from the Iraq Mental Health Survey team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The WMH Japan survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (grants H13-SHOGAI-023, H14-TOKUBETSU-026, and H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (grant R03 TW006481-01), Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, anonymous private donations to the Institute for Development, Research, Advocacy and Applied Care, Lebanon, and unrestricted grants from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Hikma Pharmaceuticals, Janssen Cilag, Lundbeck, Novartis, and Servier. The Mexican National Comorbidity Survey is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (grant CONACyTG30544-H), with supplemental support from the PanAmerican Health Organization. New Zealand Te Rau Hinengaro: The New Zealand Mental Health Survey is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Nigerian Survey of Mental Health and Well-being is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Northern Ireland Study of Mental Health is funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Chinese WMH Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Peruvian WMH Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Polish project Epidemiology of Mental Health and Access to Care was carried out by the Institute of Psychiatry and Neurology in Warsaw in consortium with the Department of Psychiatry at the Medical University in Wroclaw and the National Institute of Public Health–National Institute of Hygiene in Warsaw and in partnership with Psykiatrist Institut Vinderen, Universitet, Oslo. The project was funded by the Norwegian Financial Mechanism and the European Economic Area Mechanism as well as the Polish Ministry of Health. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, Nova University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology, and the Ministry of Health. The South Africa Stress and Health Study is supported by the US NIMH (grant R01-MH059575) and National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. The Psychiatric Enquiry to General Population in Southeast Spain–Murcia project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias of Murcia. The Ukraine Comorbid Mental Disorders During Periods of Social Disruption study is funded by the US NIMH (grant RO1-MH61905). The US National Comorbidity Survey Replication is supported by the NIMH (grant U01-MH60220) with supplemental support from the National Institute of Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (grant 044708), and the John W. Alden Trust. Work on this article was funded by a grant from the Health Research Council of New Zealand (Dr Scott).
Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank the staff of the WMH Data Collection and Data Analysis Coordination Centers for assistance with instrumentation, fieldwork, and consultation on data analysis. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.